Show simple item record

dc.contributor.authorWilson, James David
dc.date.accessioned2016-04-25T17:47:08Z
dc.date.available2016-04-25T17:47:08Z
dc.date.issued2015
dc.identifier.urihttps://hdl.handle.net/2144/16075
dc.description.abstractOtitis media is a quite common disease, especially in children due largely to their underdeveloped Eustachian tubes. One potential factor, thought to be a large contributor to the disease, is an allergic reaction causing congestion and blockage of the Eustachian tube, leaving the middle ear prone to bacterial infection and effusions. The H3 receptor has recently been discovered in the nasal mucosa of humans and rodents and is linked to the immune response. Excess histamine released in an allergic response causes nasal vascular constriction and congestion. By blocking the H3 receptor, the local vasculature may be allowed to dilate, resulting in decongestion. This could play a large role in the treatment of otitis media with effusion. The effectiveness of betahistine dihydrochloride, an H3 receptor blocker, in providing possible relief from middle ear congestion was tested using a rat model. An allergic response was induced in rats followed by one of two betahistine dihydrochloride treatment regimens: drug delivery via transtympanic or intranasal route. Changes in Eustachian tube function were monitored during this process. Four measurements were used to measure the function of the Eustachian tube: passive opening pressure, passive closing pressure, active clearance of negative pressure, and Mucociliary transit time. Lower opening pressure and closing pressure, higher clearance of negative pressure, and shorter Mucociliary transit time were indications of better Eustachian tube function. Regardless of delivery method, no significant results were found among the experimental groups to suggest improved Eustachian tube function after drug treatment. Although the middle dose of betahistine dihydrochloride (50 mg/mL) delivered transtympanically followed the expected response outcome, the trend did not achieve statistical significance. Overall, the results of this study are inconclusive for measuring the beneficial effects of betahistine dihydrochloride on Eustachian tube function. Further investigations are being conducted to measure the magnitude and duration of the effects of allergic responses on Eustachian tube anatomy and physiology.en_US
dc.language.isoen_USen_US
dc.subjectMedicineen_US
dc.subjectBetahistineen_US
dc.subjectH3 receptor blockeren_US
dc.subjectOtitis Mediaen_US
dc.subjectOvalbumin allergic modelen_US
dc.subjectEustachian tube dysfunctionen_US
dc.titleThe efficacy of betahistine as treatment for eustachian tube dysfunction in an allergic rat modelen_US
dc.typeThesis/Dissertation
dc.date.updated2016-04-08T20:14:51Z
etd.degree.nameMaster of Scienceen_US
etd.degree.levelmastersen_US
etd.degree.disciplineMedical Sciencesen_US
etd.degree.grantorBoston Universityen_US


Files in this item

This item appears in the following Collection(s)

Show simple item record